Sotagliflozin
Sotagliflozin
Sotagliflozin (pronounced soh-tuh-glih-floh-zin) is a medication used in the treatment of Type 1 diabetes and Type 2 diabetes. It is classified under the drug class known as Sodium-glucose co-transporter-2 (SGLT2) inhibitors.
Etymology
The term 'Sotagliflozin' is derived from the words 'Sodium-glucose co-transporter-2 (SGLT2)' and 'inhibitor'. The 'Sota' part of the word is a reference to SGLT2, while 'gliflozin' is a common suffix used for drugs in this class.
Usage
Sotagliflozin is used in conjunction with diet and exercise to improve blood sugar control in adults with type 1 or type 2 diabetes. It works by helping the kidneys get rid of glucose from your bloodstream.
Related Terms
- Type 1 diabetes: A chronic condition in which the pancreas produces little or no insulin.
- Type 2 diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
- Sodium-glucose co-transporter-2 (SGLT2) inhibitors: A class of prescription medicines that are FDA-approved for use with diet and exercise to lower blood sugar in adults with type 2 diabetes.
Side Effects
Common side effects of Sotagliflozin include diarrhea, nausea, and vomiting. Serious side effects may include ketoacidosis, a serious condition in which the body produces high levels of blood acids called ketones.
Precautions
Before taking Sotagliflozin, tell your doctor if you have kidney disease, liver disease, or a history of urinary tract infections or yeast infections.
External links
- Medical encyclopedia article on Sotagliflozin
- Wikipedia's article - Sotagliflozin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski